We are live on ! Find out more
OACCU

Oaktree Acquisition Corp III Life Sciences Unit
OACCU

6 hedge funds and large institutions have $9.54M invested in Oaktree Acquisition Corp III Life Sciences Unit in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

9.44% less ownership

Funds ownership: 14.41% → 4.97% (-9.4%)

45% less funds holding

Funds holding: 11 → 6 (-5)

68% less capital invested

Capital invested by funds: $29.7M → $9.54M (-$20.2M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

Holders
6
Holders Change
-5
Holders Change %
-45.45%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$206K
2
UBS Group
UBS Group
Switzerland
+$3.16K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$5.53M
2
MCM
Moore Capital Management
New York
-$5.45M
3
SSA
Schonfeld Strategic Advisors
New York
-$3.84M
4
LIP
Lighthouse Investment Partners
Florida
-$3.13M
5
WA
Whitebox Advisors
Minnesota
-$2.61M

OACCU Hedge Fund Activity: Q2 2025 in Review

6 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences Unit (OACCU) for Q2 2025, worth a combined $9.54M — down 68% from $29.7M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of OACCU and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Clear Street, adding an estimated $206K. The largest seller was Millennium Management, exiting entirely with an estimated $5.53M sold.

  • 6 institutional investors held Oaktree Acquisition Corp III Life Sciences Unit (OACCU) as of Q2 2025, down from 11 in Q1 2025.
  • Funds reported $9.54M of Oaktree Acquisition Corp III Life Sciences Unit stock for Q2 2025, down 68% quarter-over-quarter.
  • 0 funds opened new Oaktree Acquisition Corp III Life Sciences Unit positions in Q2 2025 and 5 closed out, a net change of -5 holders.
  • The largest Oaktree Acquisition Corp III Life Sciences Unit buyer in Q2 2025 was Clear Street, an estimated $206K added.
  • The largest Oaktree Acquisition Corp III Life Sciences Unit seller in Q2 2025 was Millennium Management, an estimated $5.53M sold.

Based on aggregated 13F filings for Q2 2025.